Santa Ana Bio

About Santa Ana Bio

Santa Ana Bio is a precision immunology company focused on leveraging multi-omics platforms and antibody engineering to deliver targeted therapies for patients with autoimmune and inflammatory diseases.

Products & Services

Precision Medicines:Targeted therapies for immune-mediated diseases, specifically autoimmune and inflammatory conditions.

Specialties

Precision Immunology Multi-Omics Platforms Antibody Engineering Autoimmune Diseases Inflammatory Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A and Series B T: - FT: Series A and Series B	A: 168000000 MR: - FA: 168 million FAN: 168000000	D: 2024-06-13 FD: 2024-06-13	6 investors

Series A and Series B Latest

2024-06-13

$168.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alexander Rudensky

Chairman and Member of the Immunology Program of the Sloan Kettering Institute and Lloyd Old Chair in Clinical Investigation, Investigator with the Howard Hughes Medical Institute, and Tri-Institutional Professor at MSKCC, the Rockefeller University and Cornell University

G

Graham Lord

NIHR Senior Investigator Emeritus

R

Richard Flavell

Professor

A

Ansuman Satpathy

J

Jerel Davis

Managing Director and Chairman, Ph.D.

S

Shinichiro Fuse

Partner and Managing Director at TPG Life Sciences Innovation

View 13 more team members with Pro

Unlock Full Team Directory

Recent News

Santa Ana Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised